Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen.
Wu, D., Gallagher, D.T., Gowthaman, R., Pierce, B.G., Mariuzza, R.A.(2020) Nat Commun 11: 2908-2908
- PubMed: 32518267 
- DOI: 10.1038/s41467-020-16755-y
- Primary Citation of Related Structures:  
6VQO, 6VR1, 6VR5, 6VRM, 6VRN, 6VTC, 6VTH - PubMed Abstract: 
Adoptive cell therapy (ACT) with tumor-specific T cells can mediate cancer regression. The main target of tumor-specific T cells are neoantigens arising from mutations in self-proteins. Although the majority of cancer neoantigens are unique to each patient, and therefore not broadly useful for ACT, some are shared ...